New Orleans, LA, United States of America

Robert F Garry

This inventor holds 34 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 13 EPO patents, primarily in Monoclonal Antibodies. Top assignees: The Administrators of the Tulane Educational Fund, Autoimmune Technologies, LLC, The Rockefeller University. Active years: 1994-2025.

USPTO Granted Patents = 34 (Patent Applications = 5)

% Patents Active = 61.8

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 14)

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 104(Granted Patents)

Company Filing History:

27 out of 248

The Administrators of the Tulane Educational Fund

patents

10 out of 11

Autoimmune Technologies, LLC

patents

4 out of 750

The Rockefeller University

patents

4. 2 out of 5,627

The University of Texas System

patents

5. 1 out of 1

Educational Fund and Autoimmune Technologies, LLC

patent

6. 1 out of 6

Florida Gulf Coast University

patents

7. 1 out of 1,204

Scripps Research Institute

patents

8. 1 out of 4

The Administration of the Tulane Educational Fund

patents

9. 1 out of 1

The Administrators of the Tulane

patent

10. 1 out of 1

The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC

patent

11. 1 out of 8,742

US Government as Represented by the Secretary of the Army

13. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Immunogenic Peptides

Vaccine Platforms

Viral Inhibition

Peptide Compositions

Hepatitis C

Flavivirus Inhibitors

Influenza Treatments

Stem Cells

Arenavirus Peptides

Measles Virus

Retroviral Particles

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358971 - Arena virus monoclonal antibodies and uses (2025-07-15),

2. 11198723 - Arenavirus monoclonal antibodies and uses (2021-12-14),

3. 11123427 - Immunoprotective primary mesenchymal stem cells and methods (2021-09-21),

4. 10537634 - Immunogenic peptide composition and method (2020-01-21),

5. 10472647 - Primary mesenchymal stem cells as a vaccine platform (2019-11-12),

6. 10357562 - Immunoprotective primary mesenchymal stem cells and methods (2019-07-23),

7. 10137194 - Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith (2018-11-27),

8. 9725487 - Compositions and methods for measles virus inhibition (2017-08-08),

9. 9649375 - Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith (2017-05-16),

10. 9556237 - Antiviral rift valley fever virus peptides and methods of use (2017-01-31),

11. 9434769 - Peptide compositions and methods for inhibiting herpesvirus infection (2016-09-06),

12. 9353157 - Influenza inhibiting compositions and methods (2016-05-31),

13. 9101597 - Immunoprotective primary mesenchymal stem cells and methods (2015-08-11),

14. 9056900 - Compositions and methods for coronavirus inhibition (2015-06-16),

15. 8999925 - Arenavirus inhibiting peptides and uses therefor (2015-04-07),

Title: The Innovative Journey of Robert F. Garry

Introduction: Robert F. Garry is a renowned inventor based in New Orleans, LA (US) known for his groundbreaking contributions to the field of innovations and inventions.

Latest Patents: Robert F. Garry holds several patents in the areas of biotechnology and medical devices, with his most recent patent focusing on a novel method for early detection of infectious diseases.

Career Highlights: With a career spanning over two decades, Robert F. Garry has established himself as a leading figure in the world of inventors. He has received numerous accolades for his innovative work, including the prestigious Inventor of the Year award.

Collaborations: Throughout his career, Robert F. Garry has collaborated with top research institutions, universities, and biotech companies to further his inventions. His collaborative efforts have led to the development of cutting-edge technologies that have revolutionized the field.

Conclusion: In conclusion, Robert F. Garry's passion for innovation and dedication to his craft have solidified his position as a trailblazer in the world of inventors. His work continues to inspire future generations of innovators to push the boundaries of what is possible.